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CHAPTER 1: BACKGROUND 
I. Introduction 
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the 
United States, and coronary heart disease, a primary type of CVD, kills more than 385,000 
people annually.  A frequent result of coronary heart disease is myocardial ischemia, defined as 
reduced coronary blood flow.  If blood flow is not restored within 15-20 minutes, cardiac 
myocyte death begins, which leads to a myocardial infarction (MI) (Thygesen et al., 2007).  As 
shown in Figure 1 below, although acute deaths from MI have significantly decreased over the 
past several decades, mortality and hospitalization rates due to post-MI heart failure have 
increased dramatically (Nahrendorf et al., 2010). 
 
 
Post-MI heart failure is due to cardiac remodeling, a complex process in both infarct and 
non-infarct zones, which induces changes in cardiac structure and function (Olivetti et al., 1990; 
Cohn et al., 2000; Zornoff et al., 2009).  In the infarct zone dead and dying cardiac myocytes 
release numerous cytokines and matrix metalloproteinase (MMPs) which facilitate the influx of 
inflammatory cells, such as neutrophils and monocytes, and degrade the existing extracellular 
matrix (Lindsey and Zamilpa, 2012).  Cytokines along with MMPs from the dead myocytes also 
Figure 1: Coronary heart disease statistics. A, Deaths per 100 000 population for coronary heart
disease in men, ages 35 to 74 years, United States, 1970 to 2005. B, Deaths due to heart failure,
United States, 1970 to 2005. C, Hospitalizations per 100 000 population for heart failure, age ≥
65 years, United States, 1971 to 2006. Adapted from National Heart, Lung, and Blood Institute
Fact Book 2008. (Nahrendorf et al. Circulation 2010) 
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play critical roles in the repair process by stimulating cardiac fibroblast (CF) chemotaxis and 
promoting CF infiltration into the infarct region (Sutton and Sharpe, 2000).  Infiltration and 
proliferation of CF and their differentiation into myofibroblasts are critical for the deposition of 
collagen to maintain scar thickness and stability (Holmes et al., 1997).  Collagen is needed in the 
infarct zone to maintain the integrity of the left ventricular (LV) wall due to wall thinning 
following myocyte death, or heart rupture can occur (Fang et al., 2008).  
Infarct expansion is the process in which wall thinning spreads into the border zone and 
remote regions and this leads to LV dilatation and progressive adverse cardiac remodeling 
(Boyle and Weisman, 1993).  Abnormal proliferation and differentiation of CF and excess 
collagen deposition in the remote zone play pathological roles in LV remodeling after MI (Booz 
and Baker, 1995).  Deposition of collagen in the non-infarcted myocardium is associated with 
increased myocardial stiffness and impaired diastolic heart function (Litwin et al., 1991).  
Prolonged adverse remodeling after MI contributes significantly to LV dilation and dysfunction, 
which can lead to heart failure (Pfeffer and Braunwald, 1990).  The three primary determinants 
in the development of post-MI heart failure are the size of the infarct, the wound healing 
response that occurs in the days and weeks after the MI, and chronic remodeling of the infarct 
and the remote zones (Kempf et al., 2012).  
II. Immune cells and post-MI remodeling 
Immune cells such as neutrophils, macrophages, dendritic cells, and T cells are all 
involved in post-MI remodeling (Nahrendorf et al., 2010).  Neutrophils, whose functions include 
proteolytic enzyme secretion and reactive oxygen species formation, penetrate into the infarct 
region within 2-3 hours after an MI, and peak at about one day post-MI (Nahrendorf et al., 
2010).  Then macrophages derived from circulating monocytes infiltrate into the same region.  
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One current theory regarding the subsets and the role of macrophage in post-MI remodeling is 
shown in Figure 2: 
 
 
In mice, monocytes exist as two different subsets: pro-inflammatory M1 (Ly-6Chigh) and 
anti-inflammatory M2 (Ly-6Clow).  These subsets of mouse monocytes are quite similar to human 
monocytes in which CD16- monocytes resemble mouse Ly-6Chigh monocytes, and CD16+ 
monocytes resemble mouse Ly-6Clow monocytes (Nahrendorf et al., 2010).  Peripheral Ly-6Chigh 
monocytes are recruited to the ischemic region within hours after MI occurs, with chemokine (C-
C motif) ligand 2 (CCL2) and its receptor CCR2 playing important roles (Nahrendorf et al., 
2010).  Following infiltration these Ly-6Chigh monocytes differentiate into M1 macrophages, 
Figure 2: Biphasic monocyte response after myocardial infarction in the mouse. Time course of
monocyte subset recruitment and their function depicted in the lower panel are adapted from
Nahrendorf/Swirski et al. J Exp Med 2007. PMN: neutrophil, M : macrophage, ECM:
extracellular matrix. 
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which phagocytize dead myocytes and neutrophils (Nahrendorf et al., 2010), and contribute to 
inflammation by producing inflammatory cytokines, such as IL-1β, IL-6, and TNF- (Mosser, 
2003; Fujiu and Nagai, 2013; van Nieuwenhoven and Turner, 2013).  M1 macrophages also 
express inducible nitric oxide synthase (iNOS) which uses arginine as a substrate to synthesize 
NO (Weisser et al., 2013).  Although M1 macrophages are critical in post-MI healing, it has been 
shown that the peak level of M1 macrophages is negatively associated with myocardium salvage 
in MI patients (Tsujioka et al., 2009). 
The transition from inflammation to the healing process in the post-MI heart is thought to 
be associated with the transition from M1 to M2 macrophages (Anzai, 2013).  M2 macrophages 
are differentiated from Ly-6Clow monocytes, which are recruited by fractalkine and CX3CR1 
receptor (Nahrendorf et al., 2010).  M2 macrophages secrete IL-4, TGF, and IL-10, which can 
inhibit production of pro-inflammatory cytokines (Lambert et al., 2008).  M2 macrophages also 
exhibit upregulation of constitutively expressed arginase 1, which competes with iNOS for 
arginine, by catabolizing it to ornithine and downstream polyamines and proline (Mosser, 2003; 
Weisser et al., 2013), which have been implicated in cell proliferation and collagen synthesis, 
respectively (Morris, 2009), although a role for arginase in post-MI remodeling has not been 
determined.  It has been demonstrated that M2 macrophages promote ECM reconstruction, 
fibroblast proliferation and angiogenesis (Sunderkotter et al., 1991; Cao et al., 2000; Song et al., 
2000).  Total macrophage infiltration in the infarct zone dramatically increases by day 4, then 
decreases by day 7 (Yang et al., 2002; Naresh et al., 2012), with evidence that M1 macrophages 
peak ~ day 3 and M2 macrophages peaking at 5-7 days post-MI (Nahrendorf et al., 2010).  
Extracellular matrix (ECM) destruction is initiated via the initial production of MMPs by 
neutrophils and myocytes (Lindsey and Zamilpa, 2012).  The MMP family can be divided into 
several classes based on substrate specificity: collagenases and gelatinases.  Collagenases, such 
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as MMP-1 and 8, degrade fibrillar collagen types I, II and III, whereas gelatinases, MMP-2 and 
9, degrade ECM components of the basement membrane including types IV and V collagen, 
fibronectin, and elastin (Romanic et al., 2001).  There is evidence that neutrophils can secret 
MMP-8 and 9, and myocytes express MMP-2, 3, 7, 9 and 14 (Lindsey and Zamilpa, 2012). 
Neutrophil-derived MMP-9 degrades the extracellular matrix and promotes further leukocyte 
infiltration into the infarct area (Ma et al., 2013).  Macrophages also promote ECM destruction 
(Lambert et al., 2008) by secreting matrix metalloproteinases (MMP) -1, 2 and 9 (Aikawa et al., 
2001; Soumyarani and Jayakumari, 2012).  Although increased MMP activity is a necessary 
aspect of post-MI healing and repair excessive activation can be detrimental, genetic deletion of 
MMP-9 has been reported to reduce LV dilation in a mouse MI model (Ducharme et al., 2000).  
MMP-2 KO mice have less post-MI ventricular rupture and delayed LV adverse remodeling due 
to less macrophage infiltration (Matsumura et al., 2005).  Excess infiltration of inflammatory 
cells and activation of MMP-8 and -9 is thought to contribute to post-MI heart rupture in humans 
(van den Borne et al., 2009).  The amount of MMP activation and its timing is critical as evident 
from the paradoxical observation that overexpression of MMP-9 in macrophages is associated 
with decreased inflammatory cytokine expression and improved cardiac function in the post-MI 
heart (Lindsey and Zamilpa, 2012; Zamilpa et al., 2012). 
III. Cardiac fibroblasts and post-MI remodeling 
CF play important roles in inflammation and MMPs secretion just as macrophages do.  
However, CF have one more critical function which is the production of new ECM in the form of 
collagen.  These roles of CF in post-MI remodeling are shown in Figure 3. 
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The inflammatory environment plays a very important effect on CF function.  Pro-
inflammatory cytokines, such as IL-1and TNF- which are produced by both M1 
macrophages and CF, can increase CF MMP secretion and activity, and inhibit CF collagen 
production  (Chen and Frangogiannis, 2013; Rhaleb et al., 2013; Turner, 2014).  In contrast the 
production of TGF by M2 macrophages induces CF proliferation and differentiation to 
myofibroblasts (Desmouliere et al., 1993), which are responsible for collagen deposition (Porter 
and Turner, 2009).  CF can also secrete IL-6 which promotes collagen expression in cultured CF 
(Ma et al., 2012).  Similar to macrophages, CF can also secrete MMPs, such as MMP-2 and 9 
(Aikawa et al., 2001; Xie et al., 2003; Soumyarani and Jayakumari, 2012), which degrade the 
Figure 3: Cardiac fibroblasts in responding to proinflammatory and profibrotic signals. DAMPs:
damage-associated molecular patterns; CXCL: The chemokine (C-X-C motif) ligand; CCN2:
Connective tissue growth factor; PDGF: platelet-derived growth factor; bFGF: basic fibroblast
growth factor. (van Nieuwenhoven and Turner, 2013) 
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ECM and stimulate cardiac remodeling in the post-MI heart (Lindsey, 2004; Halade et al., 2013).  
Collagen turnover in the heart is a dynamic process that involves both collagen synthesis and 
degradation (Laurent, 1987), thus there is a fine balance between ECM degradation and collagen 
production.  
Myocardial infarction not only induces CF migration and proliferation in the infarct 
region, but also in the remote zone (Chen and Frangogiannis, 2013).  Activated macrophages 
accumulate in the remote zone later than in the scar zone, and contribute to post-MI fibrosis 
(Nian et al., 2004; Lee et al., 2012; Nahrendorf and Swirski, 2013).  CF can also synthesize 
connective tissue growth factor (CTGF), platelet-derived growth factor (PDGF), and basic 
fibroblast growth factor (bFGF), which all exert pro-fibrotic effects in cardiac fibrosis (van 
Nieuwenhoven and Turner, 2013).  Excess collagen deposition into the remote zone of post-MI 
heart has been shown to be detrimental to cardiac function (Litwin et al., 1991).  
IV. Cardiac Adenosine A2AR and A2BR Receptors  
Adenosine, a purine nucleoside, whose production increases during conditions of 
hypoxia, ischemia, and inflammation, exerts its effects via four subtypes of adenosine receptors: 
A1, A2A, A2B and A3 (Linden, 2005).  All four subtypes are expressed in the heart, and the most 
well-known effects of adenosine in the normal heart are bradycardia via A1 receptors, and 
coronary vasodilation via A2AR and A2BR.  The most well recognized effects of adenosine 
receptors occur during conditions of reduced oxygen supply:demand.  Stimulation of all four 
subtypes of adenosine receptors decreases acute myocardial ischemia-reperfusion injury, 
whereas receptor blockade or deletion does not exert any acute effects (Headrick and Lasley, 
2009; McIntosh and Lasley, 2012).   
Although adenosine A2BR and A2AR are expressed in cardiac myocytes, these two 
receptors are more highly expressed in immune cells and CF (Dubey et al., 1998; Dubey et al., 
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2001; Chen et al., 2004; Kreckler et al., 2006; Hasko et al., 2008; Epperson et al., 2009; Wilson 
et al., 2011; Ehrentraut et al., 2012; Zhang et al., 2013).  A2BR are low affinity receptors and 
A2AR are high affinity receptors (Bruns et al., 1986).  Thus, higher affinity A2AR can be activated 
under normal conditions, while low affinity A2BR require high levels of adenosine, such as 
observed during stress and injury.  It is well recognized that A2AR and A2BR both couple to Gs 
proteins which in turn cause cAMP accumulation and activate downstream pathways in various 
cell types (Varani et al., 2010).  cAMP accumulation is associated with stimulation of cAMP 
response element binding protein (CREB) activity, although other kinases can also phosphorylate 
CREB (Shaywitz and Greenberg, 1999).  cAMP is generally thought to be anti-inflammatory in 
immune cells and anti-fibrotic in rat CF (Dubey et al., 2001; Ohta and Sitkovsky, 2001; Liu et 
al., 2006; Liu et al., 2008; Yokoyama et al., 2008; Villarreal et al., 2009).  A2BR can also couple 
to Gq proteins resulting in stimulation of the PLC cascade (Varani et al., 2010).  In contrast to the 
Gs pathway, Gq coupling, including that induced by A2BR, is generally pro-inflammatory and 
pro-fibrotic (Guarda et al., 1993; Brilla et al., 1994; Lijnen et al., 2001; Villarreal et al., 2009; 
Feng et al., 2010; Wilson et al., 2011).  In addition, both A2BR and A2AR increase extracellular 
signal-regulated kinase 1/2 (ERK1/2) phosphorylation (Epperson et al., 2009; Villarreal et al., 
2009), which is associated with increased collagen synthesis in CF (Chintalgattu and Katwa, 
2004; Liu et al., 2006; Gao et al., 2009).    
V. Roles of A2AR and A2BR in inflammation 
The anti-inflammatory role of A2AR has been recognized for years (Hasko et al., 2008; 
Hasko and Pacher, 2008).  In one of the first such reports, Huang et al. (Huang et al., 1997) 
showed that inhibition of lymphocyte expansion was via A2AR stimulation.  It was subsequently 
reported that activation of A2AR with a highly selective agonist reduced liver damage and TNF- 
production in a Concanavalin A (Con A)-induced liver injury mouse model, whereas genetic 
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deletion of A2AR prolonged pro-inflammatory cytokine serum levels and exacerbated liver 
damage (Ohta and Sitkovsky, 2001).  Pharmacological stimulation of A2AR increases the 
survival rate in sepsis, effects which were lost in A2AR KO mice (Sullivan et al., 2004).  Direct 
control of immune cell function has also been observed.  Kreckler et al. concluded that A2AR 
suppressed the production of TNF in mouse peritoneal macrophages (Kreckler et al., 2006).  
Another report indicated that A2AR was involved in anti-inflammatory cytokine IL-10 production 
(Csoka et al., 2007).  
The recognition of a low affinity A2 receptor subtype, the A2BR, led to numerous studies 
on the role of this receptor during inflammation.  Initial observations in A2BR KO mouse led to 
the hypothesis that this receptor exerted an anti-inflammatory role (Yang et al., 2006), which was 
supported by a report that A2BR could contribute to inhibition of macrophage TNF- production 
(Kreckler et al., 2006).  There is evidence that A2BR plays an inhibitory role in acute airway and 
lung inflammation (Zhou et al., 2009; Schingnitz et al., 2010), and genetic deletion of A2BR has 
been shown to increase mortality and inflammatory cytokine production in a mouse sepsis model 
(Csoka et al., 2010).  It has also been reported that A2BR has stimulatory effects on anti-
inflammatory M2 macrophage cytokine production (Csoka et al., 2012).   
Although there is significant support that A2BR activation exerts anti-inflammatory 
effects, there are an equal number of studies suggesting that A2BR stimulation is pro-
inflammatory.  A 2001 study by Chunn et al. showed that increased expression of the A2BR in 
the lungs of adenosine deaminase (ADA)-deficient mice (ADA is responsible for adenosine 
catabolism) in association with severe pulmonary inflammation and injury  implied a pro-
inflammatory role of this receptor in chronic inflammatory disease (Chunn et al., 2001).  A 
subsequent report indicated that that A2BR antagonism reduced airway reactivity and 
inflammation in a mouse model of allergic pulmonary inflammation (Fan et al., 2003).  There is 
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evidence that A2BR antagonists reduce elevations in pro-inflammatory cytokines as well as 
mediators of airway remodeling induced by high adenosine levels in the lungs of ADA-deficient 
mice (Sun et al., 2006).  Selective blockade of A2BR has also been shown to decrease IL-19 from 
human bronchial epithelial cells, resulting in downregulation of TNF- (Zhong et al., 2006).  
Additional studies, using A2BR KO mice, suggested that A2BR could play an important role in 
promoting chronic lung inflammatory processes including airway remodeling (Zaynagetdinov et 
al., 2010).  This conclusion was further strengthened by another group by using A2BR myeloid 
specific KO mice (Belikoff et al., 2012).  A2BR are also implicated in the stimulation of pro-
inflammatory cytokines release in several cell types (Sitaraman et al., 2001; Rees et al., 2003; 
Evans et al., 2006; Ryzhov et al., 2008a; Ryzhov et al., 2008b).     
It appears that A2BR tend to be anti-inflammatory in acute model, but exert pro-
inflammatory effects during chronic inflammation (Sun et al., 2006; Zhou et al., 2009; 
Schingnitz et al., 2010; Zaynagetdinov et al., 2010).  It is not entirely clear how A2BR have the 
dual role.  One possible explanation is that A2BR couple to both Gs and Gq proteins.  Gs proteins 
are generally considered to be anti-inflammatory, whereas Gq coupling is thought to be pro-
inflammatory.  In fact there is evidence that A2BR-induced pro-inflammatory cytokine 
production in several cell types, including immune cells and CF, is via Gq coupling (Ryzhov et 
al., 2006; Feng et al., 2010; Wilson et al., 2011).  It is possible that under chronic inflammation 
A2BR may couple more efficiently to Gq or Gs may be downregulated.   
VI. Adenosine A2 receptor subtypes and organ fibrosis 
Adenosine A2AR and A2BR, which are highly expressed on fibroblasts, have been 
reported to modulate fibrosis in several organs and alter collagen production in multiple types of 
fibroblasts.  Initial studies indicated that pharmacological stimulation of A2AR promoted wound 
closure in mice (Montesinos et al., 1997), whereas A2AR blockade and deletion protected mice 
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from bleomycin-induced dermal fibrosis (Chan et al., 2006a).  Observations from the latter group 
suggested that A2AR stimulation promoted hepatic cirrhosis (Chan et al., 2006b).  Stimulation of 
A2AR has also been shown to increase collagen production in dermal fibroblast and hepatic 
stellate cells (Chan et al., 2006a; Chan et al., 2006b; Chan et al., 2013).  Compared to A2AR, 
there are much fewer studies in A2BR effects in organ fibrosis. Dai et al. indicated that A2BR 
activation contributed to renal fibrosis by inducing IL-6 production (Dai et al., 2011).  Findings 
from another group suggested that A2BR exerted a pro-fibrotic role in pulmonary fibrosis (Sun et 
al., 2006).  In addition, the only study to date in non-cardiac fibroblasts stimulation of A2BR has 
been reported to promotes collagen expression in corpus cavernosal fibroblasts (Wen et al., 
2010).   
Despite numerous studies implicating A2AR and A2BR modulation of inflammation and 
fibrosis, there have been few studies on the roles of these receptors in chronic cardiovascular 
disease.  There have been no studies determining the role of A2AR in post-MI cardiac 
remodeling, and results of A2BR studies in cardiac remodeling are inconsistent.  Results from one 
group implied that long term stimulation of A2BR in post-MI rats reduced cardiac remodeling and 
cardiac fibrosis in the remote zone, but the nonselective adenosine receptor agonist 2-
chroloadenosine was not administered until 7-day post-MI (Wakeno et al., 2006).  In contrast, 
more recent observations in a mouse model indicated that a selective A2BR antagonist, 
administered immediately after induction of MI and continuing for 14 days, increased scar 
thickness and decreased LV remodeling (Toldo et al., 2012).  Zhang et al. concluded that 
selective antagonism of A2BR dramatically reduced cardiac fibrosis in an ischemia-reperfusion 
rat model with similar drug treatment protocol as Wakeno et al. did in their experiments (Zhang 
et al., 2013).  
Although the roles of A2AR and A2BR in promoting fibrosis and collagen production in 
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non-cardiac tissue are well recognized (Chan et al., 2006a; Chan et al., 2006b; Sun et al., 2006; 
Chan et al., 2010; Dai et al., 2011; Karmouty-Quintana et al., 2012), all studies to date in rat CF 
suggest that A2BR stimulation decreases collagen synthesis (Dubey et al., 1998; Chen et al., 
2004; Wakeno et al., 2006; Epperson et al., 2009; Villarreal et al., 2009).  In contrast a recent 
report indicated that A2BR stimulation increased collagen in human CF (Zhang et al., 2013).  The 
major limitation in all of these studies is the use of non-selective adenosine receptor agonists, 
NECA and 2-chloroadenosine, despite the fact that CF express both A2BR and A2AR (Epperson 
et al., 2009; Feng et al., 2010).  It is well known that A2BR are low affinity receptors and A2AR 
are high affinity receptors (Bruns et al., 1986).  Thus the high doses (M) of these non-selective 
adenosine receptor agonists that are required to activate A2BR also stimulate A2AR.  There are 
several reports that A2AR stimulation increases collagen production in fibroblasts and may 
contribute to organ fibrosis, however the role of A2AR in CF functions is conflicting, despite the 
use of a selective A2AR agonist (Dubey et al., 1997; Dubey et al., 2001; Chen et al., 2004).   
The discrepancies in A2AR and A2BR effects on collagen production are similar to the 
conflicting reports on the signaling effects induced by these receptors in CF.  Although the non-
selective agonist NECA increased cAMP in rat CF (Epperson et al., 2009) presumably via A2BR 
activation,  the same agonist has been reported to have no effect on the cAMP pathway in mouse 
CF (Feng et al., 2010).  Although increases in cAMP are typically associated with decreases in 
collagen synthesis (Dubey et al., 2001; Liu et al., 2006; Liu et al., 2008; Yokoyama et al., 2008), 
stimulation of A2AR, which increases cAMP accumulation exerts little, if any, effect on CF 
collagen synthesis (Dubey et al., 1998; Dubey et al., 2001; Chen et al., 2004; Epperson et al., 
2009).  Phosphorylation of ERK has been implicated in CF collagen production (Chintalgattu 
and Katwa, 2004; Liu et al., 2006; Gao et al., 2009), however the effects of A2BR on ERK 
signaling are conflicting.  Epperson et al. showed that high dose NECA increased ERK 
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activation in rat CF, but Feng et al. reported no effect of this agonist on ERK phosphorylation in 
mouse CF (Feng et al., 2010).  There are no reports of A2AR effects on ERK in CF.   
The results of numerous studies in non-cardiac tissue indicate that adenosine A2BR can 
exert anti-inflammatory effects, although there is significant evidence that in chronic models of 
inflammation A2BR is pro-inflammatory.  Pharmacological approaches examining the role of 
A2BR in chronic models of myocardial ischemia are conflicting.  Studies in cardiac fibroblasts, 
which play both beneficial and deleterious effects in the post-MI heart, are also conflicting due to 
the use of non-selective adenosine receptor agonists.  To address these deficiencies we have 
utilized the whole animal A2BR KO mouse in vivo, and a selective A2BR agonist in vitro.   
VII. Main hypothesis and aims 
The rationale of my study is shown in Figure 4.  Macrophages and CF play primary roles 
in the post-MI remodeling process and adenosine A2BR and A2AR are expressed on both cells 
types.  Although A2AR stimulation is an anti-inflammatory, current evidence suggests that this 
receptor does not significantly alter CF collagen production, so we think that is unlikely this 
receptor will alter adverse post-MI remodeling.  On the other hand there is substanatial evidence 
that A2BR is pro-inflammatory and pro-fibrotic during prolonged inflammation.  
Figure 4: Schematic rationale of 
this study. Mφ: Macrophage; ADO: 
Adenosine; CF: Cardaic fibroblasts. 
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Based on all of these facts and the three conflicting reports of A2BR in post-MI 
remodeling, the main hypothesis of my research project was that deletion of A2BR reduces 
adverse remodeling in post-MI mice, and selective activation of A2BR increases CF pro-
inflammatory cytokine production and collagen expression.  Two specific aims were tested: 
1. To determine if deletion of A2BR alters post-MI remodeling. 
2. To determine the functional roles of A2BR in murine CF. 
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CHAPTER 2: DELETION OF ADENOSINE A2B RECEPTOR PROTECTS THE HEART 
FROM ADVERSE POST-MI REMODELING 
I. Rationale 
Adenosine A2BR are highly expressed in immune cells and fibroblasts.  Significant 
evidence has accumulated indicating that adenosine A2BR can exert acute anti-inflammatory 
effects, however numerous additional reports indicate that A2BR contribute to inflammation and 
fibrosis under chronic conditions.  Similar dual roles for A2BR may exist in the heart as 
adenosine A2BR agonists have been shown to protect the acutely ischemic heart, but the chronic 
post-MI heart is associated with significant inflammation and fibrosis.  There have been few 
reports of A2BR effects in the chronically ischemic heart, and these results have been conflicting.  
The hypothesis of Aim 1 was that deletion of A2BR protected the post-MI mouse heart from 
adverse remodeling and cardiac fibrosis. 
II. Material and methods 
A. Animals 
All animals in this study were maintained and used in accordance with guidelines of the 
National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Pub. No. 
85-23, Revised 1996) and the Institutional Animal Care and Use Committee of Wayne State 
University.  Studies were performed in adult male C57BL/6 mice, 12-15 weeks of age WT 
(Jackson Laboratories, Bar Harbor, ME) and A2BR KO mice.  A2BR KO male mice were bred 
from homozygous A2BR KO breeders on a C57BL/6 background, which were generous gift from 
Dr. Stephen Tilley (University of North Carolina, Chapel Hill, NC).  
B. Mouse MI model and heart slices preparation 
Mice were anesthetized with isoflurane, intubated, and ventilated with room air using a 
positive-pressure ventilator.  A left thoracotomy was performed via the fourth intercostal space 
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and the lungs retracted to expose the heart.  After opening the pericardium, the main branch of 
coronary artery was permanently ligated with a 7-0 silk suture near its origin between the 
pulmonary outflow tract and the edge of the left atrium.  Ligation was deemed successful when 
the anterior wall of the LV turned pale.  The lungs were inflated by increasing positive end-
expiratory pressure, and the thoracotomy site was closed in layers.  Animals were kept on a 
heating pad until they recovered from anesthesia.  Analgesia was achieved with bupivacaine (1.5 
mg/kg, sc, prior to and at the conclusion of surgery) and ketoprofen (5 mg/kg, sc, 30 min prior to 
surgery and 1-day postop).  
C. RNA isolation and real-time quantitative PCR 
Five day post-MI LV tissue was harvested, separated into infarct and remote zones based 
on wall thickness and color, and RNA isolated and purified using the RNeasy Mini Kit 
(QIAGEN, Valencia, CA).  RNA quantity and quality were determined by spectrophotometry 
with TE buffer under 260 and 280 nm wavelengths.  All reagents used for reverse transcription 
and real-time PCR were purchased from Life Technologies (Grand Island, NY).  Reverse 
transcription was performed on 1 μg of total RNA, and gene expression was assayed with 
TaqMan Universal PCR Master Mix and TaqMan labeled primers according to the 
manufacturer's instructions (primer sequences were listed in Table 1).  Real-time PCR was 
conducted using the StepOnePlus Real-Time PCR System (Applied Biosystems, Carlsbad, CA).  
Data were analyzed by the comparative 2−ΔCt method, and expression of the gene of interest was 
calculated as a percentage of 18S ribosomal RNA (18S rRNA) expression.  
Table 1: Sequences of primers used in Aim I 
Gene Forward Primer Sequence 5’-3’ Reverse Primer Sequence 5’-3’ 
A2AR CACGCAGAGTTCCATCTTCA GAGAGGATGATGGCCAGGTA 
A2BR GCTATGATCGTGGGCATTTT TTTCCGGAATCAATTCAAGC 
18S rRNA GTAACCCGTTGAACCCCATT CCATCCAATCGGTAGTAGCG 
TNF-α GCCTCTTCTCATTCCTGC CTTCTCCTCCTTGTTGGG 
MMP-9 GCGGAGATTGGGAACCAGCTGTA GACGCGCCTGTGTACACCCACA 
Collagen-1 5TGCCGTGACCTCAAGATGTG CACAAGCGTGCTGTAGGTGA 
Collagen-3 GCGGAATTCCTGGACCAAAAGGTGATGCTG GCGGGATCCGAGGACCACGTTCCCCATTATG 
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D. Heart harvest and sectioning 
At 5 day or 28 day post-MI, the heart was arrested at diastole by injecting 10% KCl, and 
then excised, weighed.  After right ventricle removed, LV was weighed again to calculate 
LV/total heart ratio.  After injecting OCT into LV lumen, the LV was embedded into OCT in a 
mold.  The mold was put on a 60 mm petri dish pre-cooled by ~ 2 mL of liquid nitrogen.  The 
whole mold was put on a 100 mm petri dish sitting on dry ice, which contained adequate liquid 
nitrogen.  The sample was transferred and kept in a -80oC freezer after completely being frozen 
to wait for sectioning.  
Frozen samples were sectioned on a cryostat.  Six 5 μm thick slices were cut every 900 
m from base to apex.  Every one of six heart slices was put on a different Super Frost Plus glass 
slide.  After the sectioning was done, all of the glass slides containing heart slices were kept in 
the -80oC freezer.  
E. Trichrome staining 
The heart sample glass slide was taken out of the freezer, and allowed to sit in room 
temperature (RT) for 20 min.  Glass slide was washed in distilled water, and then fixed in 
Bouin's solution for 24 hour at RT.  Slides were rinsed under running tap water for 1 hr to 
remove the yellow color.  Then slides was stained in Weigert's iron hematoxylin working 
solution for 5 min, and rinsed under running tap water for 2 min again.  After being washed in 
distilled water, heart slices were stained in Biebrich scarlet-acid fuchsin solution for 15 minutes.  
Then slides were washed again in distilled water.  The hearts slides were then developed in 
phosphomolybdic-phosphotungstic acid solution for 25 minutes.  Slides were transferred directly 
(without rinse) to aniline blue solution and stain for 15 minutes.  After being differentiated in 1% 
acetic acid solution for 2 minutes, heart slices were washed in distilled water for the last time, 
and dehydrated very quickly through 2 changes of 95% alcohol and 2 changes of reagent alcohol 
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and cleared in xylene.  Finally, the heart slices were mounted with Permount.  The staining 
protocol was based on the protocol provided by the manufactory of Trichrome Staining Kit 
(ScyTek, Logan, UT) with minor modifications.  
F. Picrosirius red staining 
The heart sample glass slide was taken out of the freezer, and allowed to sit in RT for 20 
min.  Glass slide was washed in distilled water, and then fixed in Bouin's solution for 24 hr at 
RT. Slides were rinsed under running tap water for 1 hr to remove the yellow color.  Glass slide 
underwent several rehydration steps (100%, 95% and 70% alcohol, each for 10 seconds) and 1hr 
picrosirius red staining.  Then the slide was transferred and kept into acetic acid for 2 min.  After 
dehydration (70%, 95% and 100% alcohol, each for 10 seconds), slide was kept in xylene for 10 
min, and then mounted with cover slide and Permount.  The staining protocol was based on the 
protocol provided by the manufactory of Picrosirius Red Staining Kit (ScyTek, Logan, UT).  
G. Immunohistochemical staining for macrophage infiltration and myofibroblasts 
The methods were similar to those described by Dr. Xiao-ping Yang’s group (Xu et al., 
2007).  Frozen sections of the 5 day or 28 day post-MI hearts (5 μm) were fixed with acetone for 
1 hr and rinsed in PBS (n = 5–6).  They were pre-incubated with 0.3% hydrogen peroxide in PBS 
to inhibit endogenous peroxidase activity and then incubated with the primary antibodies, CD68 
and alpha smooth muscle actin antibodies (SMA). 
1) Macrophage: Rat anti-mouse CD68 (a marker for mouse macrophages, 1:200; Serotec) 
for 5-day and 28-day post-MI heart sections, supplemented with 5% of the species-respective 
normal serum for 1 hr at room temperature.  After washing with PBS, a secondary antibody was 
applied for 30 min at room temperature, followed by avidin-biotin complex reagent (Vector 
Labs, Burlingame, CA) for 30 min and 3-amino-9-ethylcarbazole (AEC, Vector Labs) for 30s to 
1 min to visualize positive staining.  The negative controls were processed in a similar fashion 
19 
 
except that they did not receive the primary antibody. Sections were counterstained with 
hematoxylin. 
2) SMA: 28-day sections were stained with mouse monoclonal antibody against α-
smooth muscle actin (SMA, a marker for myofibroblasts, 1:50 dilution; Sigma, St. Louis, MO), 
which was followed by a mouse to mouse staining kit ( M.O.M., Vector Labs) and then colored 
with a peroxidase substrate kit, NovaRED (Vector Labs).  Negative controls were processed in a 
similar fashion in the absence of primary antibody.  Sections were counterstained with 
hematoxylin.  
H. Data collection 
Morphological analysis 
Infarct size was measured with images of Trichrome stained 28-day post-MI heart slices 
taken by a Olympus E-10 DSLR camera.  This analysis had been described by Takagawa et al. 
(Takagawa et al., 2007).  In brief, epicardial and endocardial infarct lengths and epicardial and 
endocardial circumference of each of 7-8 heart slices from the same heart were traced manually 
in the digital images and measured automatically by the SigmaScan Pro 4.0 software (Jandel 
Scientific, San Rafael, CA).  To define the infarct lengths, endocardial infarct length was taken 
as the length of endocardial infarct scar surface that included >50% of the whole thickness of 
myocardium and epicardial infarct length as the length of the transmural infarct region.  
Epicardial infarct ratio was obtained by dividing the sum of epicardial infarct lengths from all 
sections by the sum of epicardial circumferences from all sections.  Endocardial infarct ratio was 
calculated similarly.  Infarct size derived from this approach was calculated as [(epicardial 
infarct ratio + endocardial infarct ratio)/2] × 100.   
Scar thickness and infarct expansion index were analyzed with the same Trichrome 
staining images as in infarct size measurement.  The middle heart slice which contained both scar 
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and non-infarcted region was chosen.  Scar and non-infarct wall thicknesses were measured by 
the area of scar (or non-infarct) region divided by the endocardial scar (or non-infarct) length 
(Lutgens et al., 1999).   
To quantitate both the degree of left ventricular dilation and the degree of infarct wall 
thinning, the following formula was devised: infarct expansion index (IE) equals to (LV cavity 
area /Total LV area) x (non-infarcted wall thickness/infarcted thickness).  All of the 
measurements were done by using by the SigmaScan Pro 4.0 software (Jandel Scientific, San 
Rafael, CA).  
Collagen content in remote zone of 28-day post-MI heart 
Six 200X images were taken from the remote zone of Picrosirius red stained heart slices 
with a camera attached Leica microscope.  Areas containing blood vessels and perivascular 
interstitial cells were excluded from collagen content quantification.  Red pixel contents of 
digitized images relative to total tissue area were counted using an open source analysis software 
Image J (National Institute of Health). The average of collagen content of six regions represented 
the overall collagen content.   
Myocyte cross sectional area of 28-day post-MI heart 
Three or four 200X images were taken from the remote zone of Picrosirius red stained 
heart slices.  Total 100-200 cross sectional area of myocytes were quantified. Then the numbers 
were averaged.  
Macrophage infiltration in 5-day scar and 28-day remote zones of post-MI heart 
Six 400X images were taken from scar or remote zone of CD68 antibody stained heart 
slices with the Leica microscope.  Macrophages were quantified by counting the number of 
reddish-brown cells taken equally distributed over six areas in the 5-day scar and 28-day remote 
regions of post-MI heart.  Average numbers were calculated and expressed as number per mm2.  
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-Smooth muscle actin expression in 28-day remote zone of post-MI hearts 
Percentage of the area of α-SMA positive fibroblasts was automatically detected by 
computerized image analysis system (MicroSuite Biological imaging software; Olympus 
America) on images taken with the Leica microscfOlyope at 400X. Mean values were calculated 
from 12 regions of each heart.   
I. Statistical analysis 
Data are presented as means ± SE. All of the RT-PCR data and morphological and 
histological measurements from the slice of post-MI hearts were analyzed by Student’s t-Tests.  
Statistically significant differences were taken at p<0.05.  The death and rupture rate were 
analyzed by Fisher’s exact test. 
III. Results 
Table 2: Mortality, infarct size and other important parameters 
WT A2BR KO 
Total number in each group 59 62 
Number of deaths 14 19 
Number of heart ruptures  3 6 
Mortality (%) 23.7 30.6 
Heart rupture rate (%) 5.1 9.7 
Infarct Size (%) 38.2 + 4.3 33.3 + 4.4 
LVW/BW (mg/10g) 50.1 + 2.7* 51.6 + 3.0* 
Sham LVW/BW (mg/10g) 38.0 + 1.7 41.3 + 2.5 
LW/BW (mg/10g) 64.2 + 3.8* 69.6 + 3.9* 
Sham LW/BW (mg/10g) 55.6 + 1.5 59.8 + 2.9 
The total number of animals included the animals used for 5-day post-MI gene expression and 5- and 28-
day post-MI morphological assays. Mortality was calculated as relative to the total animal number of post-
MI mice (RT-PCR, morphological and histological studies) in each group. Heart rupture rate was 
calculated with the method as same as in mortality. LVW/BW (left ventricular weight/body weight) and 
LW/BW (lung weight/body weight) were quantified from 28-day post-MI hearts. * p < 0.05 vs. sham 
group of same genotype 
Mortality, heart rupture rate, left ventricular weight (LVW)/body weight (BW), lung 
weight (LW)/BW and infarct size are shown in Table 1.  There was no significant difference in 
death and heart rupture rates between the two groups.  More importantly, our results indicated 
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that infarct size was not influenced by deletion of A2BR at 28-day post-MI.  Although knocking 
out of A2BR did not alter the LVW/BW and LW/BW ratios compared to WT MI group, the 
values of these ratios in MI groups were significantly higher than the sham groups of each 
genotype. 
 
Both A2BR and A2AR are highly expressed in immune cells (Kreckler et al., 2006; Wilson 
et al., 2011; Ehrentraut et al., 2012), which infiltrate the ischemic zone and mediate post-MI 
inflammation, thus we examined the gene expression of these two adenosine receptor subtypes in 
remote and scar zones of 5-day post-MI WT hearts.  Our initial observations indicated that 
GAPDH gene expression was increased in the scar region compared to the remote zone, thus we 
used 18S ribosomal RNA as the housekeeping gene in the semi-quantitative RT-PCR assays.  As 
shown in Figure 5, scar zone A2BR mRNA levels were 2.8 fold higher than that in remote zone (p 
Figure 5: A2BR and A2AR gene expression in remote and scar zones of WT 5-day post-MI
hearts. Left side shows gene level in remote zone, and scar zone is shown in right side. Receptor
mRNA was normalized to 18S rRNA. Data are means ± SE, * p < 0.05 vs. in remote zone of the
same genotype (n > 5 for each genotype) 
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< 0.05).  Scar zone A2AR message was decreased by > 40% in 4 of the 5 hearts (and was 
unchanged in the fifth heart), but this effect did not reach statistical significance.  
 
Figure 6 shows the effects of A2BR deletion on the gene expression of two pro-
inflammatory cytokines, TNF- and MMP-9, which have been reported to contribute to cardiac 
remodeling (Ducharme et al., 2000; Bradham et al., 2002).  As shown in Figure 6A TNF- gene 
levels in the 5-day post MI scar zone of WT hearts was 2.6-fold greater than in A2BR KO hearts 
(p<0.05); there was no difference in the remote zone.  There were no differences between the 
groups in the expressions of other cytokines, such as IL-1β and IL-6 (data not shown).  As 
summarized in Figure 6B, matrix metalloproteinase 9 (MMP-9) gene expression in the scar zone 
was 3.1-fold greater than in A2BR KO hearts (p<0.05).  One possible explanation for the 
Figure 6: mRNA of TNF- and MMP-9 in
5-day post-MI hearts. A: TNF-MMP-
9. Left shows remote and right shows scar
in both panels. mRNA of TNF- and
MMP-9 was normalized to 18S rRNA.
Data are means ± SE, * p < 0.05 vs. WT
group in the same region (remote zone or
scar zone) (n > 5 for each genotype). 
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differences in TNF- and MMP-9 expression in the A2BR KO hearts could be due to differences 
in macrophage infiltration. 
 
To identify if decreased TNF- and MMP-9 mRNA level was due to less macrophages 
infiltration, we quantified macrophage number.  Figure 7 indicates that there was no difference in 
macrophage infiltration in 5-day post-MI scar zone between the two groups, based on 
immunohistochemical staining with anti-CD86.  
A             B 
Figure 7: Effects of deleting A2BR in macrophage 
infiltration in scar zone of 5-day post-MI hearts. 6 
different regions images were taken from anti-
CD68 antibody stained sections under 400X 
magnification. Data are means ± SE. 
Figure 8: Collagen 1 and 3 gene expression in 5-day post-MI hearts. A: Collagen-1, B: Collagen-
3. mRNA of both collagen subtypes was normalized to 18S rRNA. Data are means ± SE, * p <
0.05 vs. WT group in the same region (remote zone or scar zone) (n = 5 for WT; n = 6 for A2BR
KO).  
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Collagen synthesis is a necessary aspect of rebuilding the thinned wall in the infarct zone, 
but excess collagen synthesis in the remote zone can lead to fibrosis and decreased cardiac 
function (Jalil et al., 1989; Litwin et al., 1991; Fang et al., 2008).  As shown in Figure 8 
collagen-1 and collagen-3 gene expressions were significantly reduced in 5-day scar and remote 
zones in A2BR KO hearts.  Collagen-1 and collagen-3 gene expressions in the remote zone were 
96% and 64%, respectively, greater in WT hearts compared with A2BR KO hearts (p < 0.05).  
There were no differences between the groups in scar zone collagen isoform mRNAs.  
 
 
Reduced post-MI inflammation and improved healing are associated with increased scar 
thickness and reduced infarct expansion, and our findings on these morphological aspects of 28-
day post-MI hearts are illustrated in Figure 9.  A2BR KO hearts exhibited significantly thicker 
scars (0.36 + 0.03 mm vs. WT 0.29 + 0.02 mm) and less infarct expansion (1.57 + 0.19 vs. WT 
2.81 + 0.38) compared with WT hearts (p < 0.05). 
Figure 9: A2BR effects in 28-day post-MI remodeling. Left Y axis: scar thickness; right Y axis:
infarct expansion index. Quantifications were achieved from Trichrome stained heart slices. 
Data are means ± SE, * p < 0.05 vs. WT group (n = 11 for WT; n = 10 for A2BR KO). 
26 
 
 
 
We next examined another parameter, myocyte cross sectional area, to evaluate if 
deletion of A2BR showed any effect in 28-day post-MI myocyte hypertrophy as shown in Figure 
10.  Our data indicated that there was no significant difference between the two genotypes.  
 
 
 
 
 
 
Figure 11 demonstrates the collagen content in the remote zone based on Picrosirius red 
staining.  A2BR KO hearts (0.89 + 0.11% of the total area, p <0 .05) contained less collagen 
compared to WT hearts (1.29 + 0.01% of the total area).   
Figure 10: A2BR effects in 28-day post-MI myocyte hypertrophy. Myocyte cross sectional area
was calculated by the mean of 100-200 randomly picked myocytes from Picrosirius red stained
heart slices. Images were taken under 200X magnification. Data are means ± SE. (n = 11 for
WT; n = 9 for A2BR KO). 
Figure 11: Collagen content in 
28-day post-MI heart remote 
zone. 6 pictures were taken 
from Picrosirius red stained 
sections with 200X 
magnification. Data are means 
± SE, * p < 0.05 vs. WT group 
(n > 6 for each genotype). 
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To determine if the decreased remote zone collagen content in A2BR KO hearts was due 
to differences in myofibroblast density, we assessed SMA expression, a marker of 
myofibroblasts.  As shown in Figure 12 there was no difference in remote zone SMA expression. 
 
It has been documented that activation of myofibroblasts is also influenced by 
macrophages (Kong et al., 2014), so we next investigated macrophage infiltration in the remote 
zone (Figure 13).  Immunohistochemical detection of macrophages with anti-CD86 indicated 
that deletion of A2BR was associated with significantly reduced macrophages in the remote zone 
(304 + 38/mm2) compared to WT hearts (371 + 30/ mm2 in WT, p < 0.05). 
 
  
Figure 12: alpha smooth muscle actin 
(SMA) expression in 28-day post-MI 
remote region. Sections were stained 
with anti-SMA antibody. 12 different 
images were taken under 400X. Data are 
means ± SE (n = 6 for WT; n = 5 for 
A2BR KO). 
Figure 13: A2BR effect in macrophage 
infiltration of 28-day post-MI remote 
zone. Staining and imaging conditions 
were as same as in Fig. 6.  Data are 
means ± SE, * p < 0.05 vs. WT group 
(n = 8 for each genotype). 
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CHAPTER 3: SELECTIVE ACTIVATION OF A2BR PROMOTES COLLAGEN AND 
PROINFLAMMATORY CYTOKINE PRODUCTION 
I. Rational 
Observations in the first Aim showed that deletion of A2BR reduced pro-inflammatory 
cytokine gene level in the scar region at early stage of post-MI and decreased collagen deposition 
in the remote zone at both 5 and 28-day post-MI, so we investigated these results at the cellular 
level.  Cardiac fibroblasts, which make up a large portion of total cells in the heart, are 
responsible for modulating ECM under both physiological and pathological conditions.  The 
function of CF is not only limited to collagen production, but also include cytokine, chemokine 
and MMP secretion.  Adenosine A2BR are highly expressed in CF, but the results of existing 
studies determining the role of this receptor are conflicting.  Given that A2AR are also expressed 
on CF, a major limitation of these studies is the use of non-selective agonists.  The purpose of 
Aim 2 studies was to determine the effects of selective A2BR stimulation on CF function.  The 
hypothesis of Aim 2 was that selective activation of A2BR in murine CF promoted collagen and 
pro-inflammatory cytokine production. 
II. Materials and methods 
A. Animals 
Besides WT and A2BR KO mice which I already described in Aim I, we also used A2AR 
KO mice.  A2AR KO male mice were bred from homozygous A2AR KO breeders on a C57BL/6 
background, which were generous gifts from Dr. Joel Linden (La Jolla Institute for Allergy and 
Immunology, La Jolla, CA).  
B. Drugs 
The A2AR agonist CGS-21680 (CGS), the non-selective agonist 5'-N-
ethylcarboxamidoadenosine (NECA), and angiotensin II were purchased from Sigma-Aldrich 
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(St. Louis, MO).  The A2B receptor agonist BAY 60-6583 (BAY) was a kind gift from Dr. 
Thomas Krahn (Bayer Healthcare, Wuppertal, Germany).  The adenosine A2B receptor antagonist 
N-(4-cyanophenyl)-2-[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-
yl)phenoxy]-acetamide (MRS1754) and the PKA inhibitor H89 were purchased from Tocris-
Cookson (Bristol, UK).  The MEK inhibitor U0126 was purchased from LC Laboratories 
(Woburn, MA). 
C. Cell culture 
Hearts were excised from anesthetized (2~3% Isofluorane) and heparinized (500 units) 
mice, placed in ice-cold saline, and mounted on a 20-gauge cannula.  The hearts were perfused 
with CF isolation buffer (in mM: 120 NaCl, 4.7 KCl, 1.2 MgSO4, 1.2 KH2PO4, 10 HEPES, 10 
BDM, 5 NaHCO3, 20 Taurine, 11 Glucose, pyruvic acid 5, creatine 20).  After the solution being 
warmed up to 37 °C, pH value was adjusted to 7.2.  Following 3.5 minutes of perfusion with 
isolation buffer, the heart was perfused with isolation buffer containing collagenase B (0.5 
mg/mL), collagenase D (0.5 mg/mL) and CaCl2 (50 µM).  The heart was digested for 10~12 
minutes until coronary perfusion pressure drop to ~30mmHg.  The heart was removed from the 
cannula, and minced in isolation buffer (with 50 µM calcium chloride and 10% FBS) using a 
plastic pipette after cutting the atrial appendages.  The CF was then be filtered through a mesh, 
and settled by gravity in a 15 mL conical tube at room temperature for 15~20 min.  The 
supernate was collected into a new 15 mL conical tube and centrifuged at 1800 rpm for 3 min.  
The pellet was resuspended in 5 mL complete Dulbecco’s modified Eagle’s medium (DMEM, 
10 % FBS and 100 U/mL Penicillin/Streptomycin).  CF were plated on a 60 mm diameter culture 
dish in an incubator (37°C, 5% CO2).  Culture medium was changed 1 hour and 24 hour after 
plating to remove unattached cells.  CF were split into 5 dishes when reaching 70~80% 
confluence.  CF were starved by changing culture medium into serum free DMEM with or 
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without ascorbic acid (0.05 mg/ml) when cells reaching 70~80% confluence after the first 
passage. Drug treatments were start until 24 hour starvation.  
D. Drug treatment protocols 
Adenosine A2BR and A2AR receptor effects on ERK and CREB pathways (n > 4 for each 
group) were assessed in serum-starved CF treated for 10 min with Veh, CGS (500 nM) and BAY 
(500 nM).  The selectivity of CGS and BAY as agonists of A2AR and A2BR, respectively, has 
been well-established (Fredholm et al., 2001; Auchampach et al., 2009).  To determine if 
adenosine receptor effects on CREB were PKA dependent, a subset of cells was pretreated with 
the PKA inhibitor H89 (5 M) for 30 min prior to agonist treatments.  CF isolated from A2A and 
A2B KO mice were used to confirm that the signaling effects induced by CGS and BAY were 
A2AR and A2BR-dependent, respectively.  
Since A2AR and A2BR both increase cAMP in CF, an effect which is generally associated 
with inhibition of collagen synthesis, we first evaluated the effects of selective A2AR and A2BR 
agonists on TGF-induced collagen expression.  Serum-starved CF were treated for 24 h with 
TGF (10 ng/mL) alone or in the presence of CGS (500 nM), BAY (500 nM) or NECA (5 M) 
(n > 4 for each group).  Additional sets of CF (n > 6 for each group) were treated with adenosine 
receptor agonists alone to assess their effects on collagen expression.  Ascorbic acid (0.05 
mg/ml) was added to the serum-free medium 24 h prior to the addition of agonists and during the 
24 h treatments. In the final series of experiments, A2AR and A2BR agonist effects on collagen 
synthesis were repeated in the presence of the MEK inhibitor, U0126 (10 M), or H89 (5 M).  
The inhibitors were administered 30 min prior to the receptor agonists.  
For pro-inflammatory cytokine gene expression study, serum-starved WT CF (n > 4 in 
each group) were treated with vehicle (Veh, 0.01% DMSO), the A2AR agonist CGS (500 nM), 
and the A2BR agonist BAY (500 nM) for 24 h.  A schematic drug treatment protocol is shown in 
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Figure 14. 
 
 
E. Cell harvest and Western blotting 
After agonist stimulations, culture dishes were washed with cold PBS prior to lysing with 
NP-40 lysis buffer supplemented with 1% Triton and protease and phosphatase inhibitors.  The 
protease inhibitor cocktail (Sigma Chemical Co., St. Louis, MO) includes AEBSF (2 mM), 
Aprotinin (0.3 μM), bestatin (130 μM), E-64 (14 mM), leupeptin (1 mM) and EDTA (1 mM).  
The phosphatase inhibitor contains 100 mM sodium fluoride, 50 mM sodium pyrophosphate 
decahydrate, 50 mM sodium orthovanadate, 100 mM β-glycerophosphate 100X concentrate 
(Boston Bio, Ashland, MA).  Lysates were sonicated, centrifuged at 10,000g (5 min, 4oC), and 
the resulting supernatants were stored at -80oC.  Denatured protein samples (10-15 g protein), 
heated to 50oC for signaling studies and boiled for collagen-1 expression studies, were separated 
using SDS-PAGE (10% resolving gels for kinases, 6% resolving gels for collagen-1).  Following 
transfer, nitrocellulose membranes were incubated with primary antibodies overnight (4°C with 
gentle rocking) in TBST with 2.5% BSA for anti-phospho-kinase (pERK and pCREB) antibodies 
and 1% milk for collagen-1 and tubulin.  Membranes were then incubated with secondary 
Figure 14: Schematic CF drug treatment protocol. 
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antibodies for one hour at room temperature in TBST with 1% milk.  Protein visualization was 
performed using enhanced chemiluminescence and autoradiography.  Phospho-kinase blots were 
stripped and reprobed with antibodies for total ERK and CREB for normalization, while collagen 
data were normalized to tubulin.  Optical density of bands was quantified using UN-SCAN-IT 
gel version 6.1 (Silk Scientific Inc, Orem, Utah).   
F. RNA isolation and real-time quantitative PCR  
For GPCR and cytokine gene expression assay, RNA was isolated from serum-starved 
WT CF (n > 3) using the RNeasy Plus Mini Kit per manufacturer’s instructions (QIAGEN, 
Valenica CA).  The procedures of reverse transcription and RT-PCR were as same as the 
information described in Aim 1 Methods except the expression of the gene of interest was 
calculated as a percentage of GAPDH expression this time.  The primer sequences except A2AR 
and A2BR, which have been shown in Table 1, are listed in Table 3. 
Table 3: Sequences of primers used in Aim 2. 
Gene Forward Primer Sequence 5’-3’ Reverse Primer Sequence 5’-3’ 
AT1R AACAGCTTGGTGGTGATCGTC CATAGCGGTATAGACAGCCCA 
β2R CCTCATGTCGGTTATCGTCC GGCACGTAGAAAGACACAATC 
GAPDH TCTACATGTTCCAGTATGACTC ACTCCACGACATACTCAGCACC 
IL-1β  GCTAGGGAGCCCCCTTGTCGAG AGGCAGGGAGGGAAACACACGTT 
IL-6 TCCGCAAGAGACTTCCAGCCAG  TGTGAAGTAGGGAAGGCAGTGGC 
G. Statistical analysis 
Data were analyzed with GraphPad Prism software and are presented as means ± SE.  
Signaling, collagen and cytokine expression were analyzed by one-way ANOVA.  Statistically 
significant differences were taken at p<0.05.  
III Results 
Although CF were isolated according to standard protocols and the medium was 
exchanged twice in the first 24 hours to remove non-adherent and contaminating cells, it is very 
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difficult to obtain pure cell isolations.  Since non-fibroblasts, macrophages and other immune 
cells, could contribute to our observations, we assessed the purity of our CF cultures.  As shown 
in Figure 15, DDR2 mRNA level were ~ 10 fold greater than the levels of the two immune cell 
markers.  These findings support the fidelity of our CF cultures. 
 
Figure 16 illustrates that murine CF exhibit considerable A2BR and A2AR gene 
expression, with A2BR being approximately three-fold greater than that of A2AR. Little A1R and 
A3R expression was observed (data not shown). Gene expression of A2BR was much greater than 
that for adrenergic (R and A2AR expression was comparable to that of angiotensin 
receptor type I subtype (AT1R).   
 
 
 
Figure 16: Gene expression of 
CF adenosine, β2R and 
angiotensin receptor type I 
receptors (n=3).  Results are Data 
are means ± SE, expressed as 
percentage of GAPDH. 
Figure 15: Purity of cultured murine CF. 
DDR2 (discoidin domain receptor 2): a 
specific maker for CF; F4/80 is a 
macrophage marker and CD11b is a marker 
for macrophages and other immune cells. 
Data are means ± SE, n = 3. 
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Activation of ERK is thought to play a role in CF collagen production (Chintalgattu and 
Katwa, 2004; Liu et al., 2006; Gao et al., 2009), and adenosine receptor agonist effects on ERK 
phosphorylation are shown in Figure 17.  Representative blots of phospho-ERK and total ERK 
are shown in Figure 17A.  Figure 17A also indicated that the CGS-mediated increase in ERK 
phosphorylation was abolished by deletion of the A2AR.  Additionally the BAY-mediated 
increase in ERK phosphorylation was blocked by the selective A2BR antagonist MRS1754 and in 
A2BR KO CF.  The effect of the non-selective agonist NECA on ERK activation was also 
reduced, but not eliminated, by MRS1754.  Figure 17B presents the summary results of p44 ERK 
phosphorylation.  The A2BR agonist BAY and the A2AR agonist CGS increased ERK 
phosphorylation 3.7 ± 0.4 and 5.3 ± 1.0 fold, respectively, vs. the Veh group (p < 0.05).  
 
 
Figure 17: ERK phosphorylation following 10 min treatments with selective A2BR (BAY, 500 
nM) and A2AR (CGS, 500 nM) agonists. The upper band shows the p44 ERK, and lower one 
represents the p42 ERK. (A) Representative Western blots for CGS and BAY effects on ERK 
phosphorylation in WT, A2AR and A2BR KO CF. Also shown are the effects of the A2BR 
antagonist MRS1754 on NECA (5 M) and BAY effects in WT CF.  (B) Quantified p44 pERK 
relative to ERK (normalized to Veh), data were expressed as relative to Veh group, n = 7 for 
BAY, n = 6 for CGS. Data are means ± SE. *p<0.05 vs. Veh.  
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Both A2AR and A2BR couple to Gs proteins, resulting in increased cAMP levels and PKA-
dependent phosphorylation.  To determine the effects of selective A2AR and A2BR on this 
signaling pathway, we assessed serine-133 phosphorylation of the cAMP response element-
binding protein (CREB).  As shown in Figure 18 both BAY and CGS increased CREB 
phosphorylation (29.7 ± 8.7 fold and 5.7 ± 0.9 fold for BAY and CGS, respectively, p < 0.05 vs. 
Veh).  These effects were significantly reduced by the PKA inhibitor H89 (7.3 ± 2.4 fold for 
BAY, 2.8 ± 0.6 fold for CGS).  
 
 
Figure 18: Effects of BAY and CGS on CREB phosphorylation in the absence and presence of
the PKA inhibitor H89 (5 µM). CF were treated as described in Figure 16; H89 was
administered 30 min prior to the agonists. The molecular weight (MW) of CREB is 43 kDa. (A)
Representative Western blots. (B) Quantification of pCREB relative to CREB, normalized to
Veh. n ≥ 4 per group. Data are means ± SE. *p<0.05 vs. Veh.
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Increases in cAMP typically inhibit collagen synthesis, thus we determined the effects of 
adenosine receptor agonists on TGFβ-induced collagen-1 expression.  As illustrated in Figure 19, 
TGFβ increased collagen-1 expression 2.1 ± 0.4 fold compared with Veh treatment (p < 0.05). 
None of the adenosine receptor agonists altered the TGFβ effects on collagen (3.0 ± 1.0 fold 
increase for BAY, 3.1 ± 1.0 fold for CGS and 2.3 ± 1.9 fold for NECA). 
 
 
Since stimulation of A2BR and A2AR did not decrease collagen expression induced by 
TGFβ, we assessed the effects of these receptor agonists alone on collagen-1 expression (Figure 
20).  Representative blots of collagen-1 and tubulin are shown in Figure 20A.  Both BAY and 
Figure 19: Collagen-1 expression in CF treated with TGF (10 ng/mL) with or without BAY
(500 nM), CGS (500 nM) and NECA (5 M) for 24 h. MW of collagen-1 is about ~ 130 kDa.
(A) Representative Western blots for collagen-1 and tubulin. (B) Fold increase in collagen-1
expression relative to Veh group with TGF n ≥ 4 per group. Data are means ± SE. *p<0.05 vs.
Veh. 
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CGS significantly increased collagen-1 production compared to the Veh group (2.3 ± 0.3 fold for 
BAY, 2.2 ± 0.3 fold for CGS, p < 0.05).  The non-selective adenosine receptor agonist NECA 
increased collagen-1 levels 2.6 ± 1.1 fold (p < 0.05 vs Veh) (Figure 20B).  
 
Since BAY and CGS stimulated ERK phosphorylation, and ERK activation appears to 
play a key role in CF collagen production (Chintalgattu and Katwa, 2004; Liu et al., 2006; Gao et 
al., 2009), we tested the effects of the MEK inhibitor U0126 on adenosine receptor-mediated 
increases in collagen.  PKA inhibition has been reported to block adenosine A2AR-induced 
collagen production in fibroblasts (Che et al., 2007; Perez-Aso et al., 2013b), thus we also tested 
the effects of the PKA inhibitor H89 on CF collagen expression.   As shown in Figure 20B the 
Figure 20: Adenosine receptor 
agonist effects on collagen-1 
expression. The effects of selective 
A2AR and A2BR stimulation were 
assessed in the presence and 
absence of the PKA inhibitor H89 
(5 µM) and the MEK inhibitor 
U0126 (10 µM). (A) Representative 
Western blots for collagen-1 and 
tubulin. (B) Summarized collagen-1 
results expressed relative to Veh 
group (n = 6-9 per group). Data are 
means ± SE. *p<0.05 vs. Veh.  
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ability of selective A2BR and A2AR agonists to increase CF collagen levels is significantly 
reduced by both U0126 and H89.   
Acute stimulation of A2AR and A2BR is associated with anti-inflammatory effects 
(Bshesh et al., 2002; Antonioli et al., 2014).  Additional reports indicate that activation of A2BR 
can also promote pro-inflammatory cytokine production (Ryzhov et al., 2006; Wilson et al., 
2011).  Thus, we assessed gene expression of IL-1 and IL-6 in WT CF (Figure 21).  Neither 
agonist showed altered IL-1 gene expression, but BAY (2.4 ± 0.1 fold), not CGS, significantly 
increased IL-6 mRNA levels.  
 
 
  
Figure 21: Selective A2BR and A2AR agonist effects on pro-inflammatory cytokine gene 
expression.  Treatment conditions were identical to the conditions described in Fig. 18 and 19. 
Cytokine expression was normalized to percentage of GAPDH. Data are means ± SE. *p<0.05 
vs. Veh. n > 3 per group. 
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CHAPTER 4: DISCUSSION 
I. Summary 
A summary of the important findings is listed below:   
1. A2BR gene expression in the scar region increased significantly in the 5-day post-MI WT 
heart, a time that is associated with significant inflammation.  
2. Ablation of A2BR decreased TNF- and MMP-9 gene expression in the 5-day infarct 
zone, consistent with decreased inflammation.  
3. At 28-days post-MI A2BR KO hearts exhibited increased scar thickness and decreased 
infarct expansion.  
4. Deletion of A2BR deceased macrophages infiltration and collagen deposition in remote 
zone of 28-day post-MI heart, but did not downregulate myofibroblast expression.  
5. A2BR and A2AR are highly expressed in adult murine CF.   
6. Selective activation of both A2BR and A2AR increased ERK and CREB phosphorylation.  
7. Both Gs coupled adenosine receptors failed to inhibit TGF-induced collagen-1 
expression.  
8. Stimulation of A2BR and A2AR alone increased collagen expression, effects that were 
significantly blunted by MEK and PKA inhibitors.  
9. Activation of A2BR, but not A2AR, increased IL-6 gene expression.  
II. Contrasting roles of A2BR in acute and chronic ischemic myocardium 
Although A2BR are the least characterized of the four adenosine receptor subtypes 
expressed in the heart, there are multiple reports that A2BR agonist stimulation is cardioprotective 
in the setting of acute myocardial ischemia-reperfusion injury (Kuno et al., 2007; Xi et al., 2009; 
Methner et al., 2010).  Such studies also indicate that treatment with A2BR antagonists or deletion 
of A2BR does not exacerbate acute injury (Maas et al., 2010; Methner et al., 2010; Zhan et al., 
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2011).  However the few studies examining the role of A2BR in chronic models of MI are 
contradictory.  Results from one group suggested that long-term stimulation of A2BR decreased 
post-MI remodeling and fibrosis (Wakeno et al., 2006), whereas two more recent studies 
indicated that A2BR blockade reduced adverse cardiac remodeling (Toldo et al., 2012; Zhang et 
al., 2013).  Our current findings support the latter two studies indicating that A2BR contribute to 
adverse remodeling in the chronic post-MI heart.  
III. Pro-inflammatory effects of A2BR in post-MI heart 
One of our initial findings was that A2BR mRNA was significantly increased in the scar 
zone of 5-day WT post-MI hearts compared to the remote zone.  A2BR are highly expressed on 
immune cells, such as macrophages, dendritic cells and regulatory T cells (Kreckler et al., 2006; 
Wilson et al., 2011; Ehrentraut et al., 2012), and macrophage infiltration in the infarct zone peaks 
on days 4-5 (Yang et al., 2002; Naresh et al., 2012).  Thus the increase in scar zone A2BR 
expression may be due to the increase in immune cell infiltration and proliferation.  In addition 
A2BR are upregulated in immune cells under inflammatory conditions (Chen et al., 2009; Ruiz-
Garcia et al., 2011).  Our observations that A2BR are upregulated in the infarct zone within days 
after MI, and A2BR deletion is associated with increased scar thickness, decreased infarct 
expansion, and reduced collagen deposition in remote zone support the hypothesis that increased 
A2BR signaling contributes to adverse post-MI remodeling.  In contrast to A2BR, A2AR gene 
expression tended to decrease in the early post-MI period.  A recent report indicated that A2AR 
expression in macrophages was down-regulated by low molecular weight fragments of 
hyaluronan (Collins et al., 2011), a component of the extracellular matrix, and hyaluronan levels 
have been reported to increase in within days of an MI (Waldenstrom et al., 1991).  
One of the possible explanations for the decreased remodeling in A2BR KO hearts could 
be decreased post-MI inflammation.  Deletion of A2BR significantly decreased 5 day post-MI 
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expression of TNF- and MMP-9, both of which have been reported to increase after MI and 
contribute to remodeling (Heymans et al., 1999; Ducharme et al., 2000; Peterson et al., 2000; 
Ramani et al., 2004; Sun et al., 2004; Monden et al., 2007).  It has also been reported that TNF- 
induces MMP-9 upregulation in multiple cell types, including monocytes and macrophage 
(Vaday et al., 2001; Li et al., 2006).  Our findings are consistent with reports that A2BR 
stimulation is associated with pro-inflammatory cytokine production in several cell types, 
including CF (Ryzhov et al., 2006; Feng et al., 2010; Wilson et al., 2011).  In addition selective 
A2BR antagonists have been shown to significantly inhibit pulmonary inflammation, and deletion 
of A2BR (whole animal and myeloid cell-specific) has also been reported to decrease chronic 
inflammation (Sun et al., 2006; Mustafa et al., 2007; Belikoff et al., 2011; Belikoff et al., 2012). 
Our observations are the first report of the effects of A2BR deletion in a chronic post-MI model.  
IV. Comparison of our results with other reports  
Deletion of A2BR had no effect on infarct size but did increase scar thickness and 
decrease infarct expansion at 28 days post-MI.  A thicker scar has been shown to increase post-
MI cardiac function (Dai et al., 2005), whereas infarct expansion into the border zone 
exacerbates wall thinning and ventricular dilation (McKay et al., 1986; Pfeffer and Braunwald, 
1990).  The finding that A2BR deletion did not alter infarct size, which is consistent with previous 
observations in acute MI models (Maas et al., 2010; Methner et al., 2010; Zhan et al., 2011), 
indicates that A2BR KO reduced adverse post-MI remodeling.  Our results are also consistent 
with two previous reports in models of chronic myocardial ischemia using a selective adenosine 
A2BR antagonist (Toldo et al., 2012; Zhang et al., 2013). Toldo et al. (Toldo et al., 2012) first 
reported that the administration of GS-6201 immediately following a permanent occlusion and 
continuing for 14 days resulted in a thicker scar, less LV hypertrophy and improved post-MI 
cardiac function in mice after 4 weeks.  This group reported that GS-6201 treatment significantly 
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decreased plasma levels of IL-6 and TNFα at 28 days post-MI, but did not measure collagen.  In 
contrast we measured infarct and remote zone inflammation at 5 days and collagen deposition in 
the remote zone at 28 days.  In a chronic occlusion-reperfusion model in rats, the same A2BR 
antagonist administered at one week post-MI reduced fibrosis and improved ventricular function 
(Zhang et al., 2013).  Conversely, Wakeno et al. (Wakeno et al., 2006) concluded that long term 
stimulation of A2BR protected the heart against MI.  However these authors administered a non-
selective adenosine receptor agonist one week after the MI, and the effect of an A2BR antagonist 
alone was not tested (Wakeno et al., 2006).   
A2BR KO hearts exhibited decreased collagen-1 and 3 gene expression in the remote zone 
of 5-day post-MI and less collagen deposition in the remote zone at 4 weeks.  It has been well 
documented that excess collagen increases myocardial stiffness and decreases cardiac function 
(Jalil et al., 1989; Litwin et al., 1991).  Our observations in A2BR KO hearts are consistent with 
those of Toldo et al. (Toldo et al., 2012) and Zhang et al. (Zhang et al., 2013) who reported that 
post-MI treatment with a selective A2BR antagonist increased ventricular function and reduced 
interstitial collagen content, respectively.  Our findings are also consistent with reports that A2BR 
contribute to fibrosis in other organs (Sun et al., 2006; Dai et al., 2011).  The reduced collagen 
expression in 28 day post-MI remote zones of A2BR KO hearts did not appear to be due to 
decreased myofibroblast expression, however this could be due to reduced macrophage 
infiltration in the remote zone, since macrophages play an important role in cardiac fibrosis 
(Nian et al., 2004; Lee et al., 2012; Nahrendorf and Swirski, 2013).  
The present findings in the whole animal KO as well as the observations with selective 
A2BR antagonists indicate that A2BR modulate cardiac remodeling independent of infarct size 
(Toldo et al., 2012; Zhang et al., 2013).  These results differ from those of Ryzhov et al. (Ryzhov 
et al., 2013), who reported that injection of WT stem cells into the peri-infarct area of 
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permanently occluded mouse hearts increased post-MI ventricular function, a beneficial effect 
that was absent when using A2BR KO stem cells.  However an important difference in the study 
by Ryzhov et al. (Ryzhov et al., 2013), is the fact that their intervention significantly decreased 
infarct size.  Thus the presence of A2BR on a small population of cells may play a 
cardioprotective role in the very early period following an MI. 
Deletion of A2BR reduced levels of TNF- and MMP-9 in the early post-infarct period 
consistent with decreased inflammation, and this was associated with less adverse remodeling.  
The reduced fibrosis in A2BR KO post-MI hearts at 28 days could be due to lower inflammation 
and/or improved healing.  However since A2BR are highly expressed on CF, the beneficial effects 
of A2BR deletion could be due, in part, to direct effects on CF. 
V. Effects of selective adenosine A2BR and A2AR activation in CF 
One of our most important observations is that stimulation of A2BR alone, under serum-
free conditions, increased collagen expression.  There is significant evidence that stimulation of 
A2BR are associated with increased fibroblast collagen synthesis and organ fibrosis (Sun et al., 
2006; Feng et al., 2010; Wen et al., 2010; Dai et al., 2011; Karmouty-Quintana et al., 2012; 
Zhang et al., 2013).  However, the results of existing CF studies suggest that A2BR stimulation 
decreases collagen synthesis (Dubey et al., 1998; Dubey et al., 2001; Chen et al., 2004; Wakeno 
et al., 2006; Villarreal et al., 2009).  The deficiency in CF studies examining the role of A2BR is 
the use of non-selective agonists, such as NECA and 2-chloroadenosine.  High concentrations 
(μM) of NECA are needed to activate low affinity A2BR, but nM doses of NECA activate high 
affinity A2AR.  Our current findings that A2BR and A2AR are both expressed in CF, with A2BR 
mRNA levels being two-fold greater than that of A2AR, are similar to observations in rat CF 
(Epperson et al., 2009).  Given the significant A2AR expression in CF, results obtained with 
NECA cannot be attributed exclusively to A2BR.  Our observations thus provide the first report 
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of selective A2BR activation in CF.  The agonist BAY 60-6583 is a relatively new, highly 
selective agonist for mouse A2BR (Auchampach et al., 2009).  The A2BR selectivity of BAY in 
the present study is supported by the observations that the signaling effects of this agonist were 
blocked by the A2BR antagonist MRS1754 and by deletion of A2BR.  Likewise, the effects of the 
well-characterized A2AR agonist CGS were blocked by deletion of A2AR.   
Interestingly Chen et al. (Feng et al., 2010) reported that although non-selective A2BR 
activation slightly decreased serum-induced increases in collagen in rat CF, this same treatment 
increased collagen synthesis after A2BR overexpression.  In addition a recently published report 
indicates that NECA (10 µM) increased collagen expression in human CF, an effect that was 
completely blocked by a selective A2BR antagonist (Zhang et al., 2013).  In contrast Villarreal et 
al. (Villarreal et al., 2009) demonstrated that NECA alone did not alter collagen expression under 
serum-free conditions.  Our observations with both high concentrations of NECA and the A2BR 
selective agonist BAY indicate that A2BR stimulation increases collagen in mouse CF.  Our 
observations that selective A2BR stimulation increased CF collagen are consistent with findings 
in corpus cavernosal fibroblasts (Wen et al., 2010). 
Our data also showed that stimulation of A2AR also promote mouse CF collagen 
expression.  This observation is consistent with the results of A2AR studies in dermal and hepatic 
stellate cells (Chan et al., 2006a; Che et al., 2007; Chan et al., 2013; Perez-Aso et al., 2013a).  In 
contrast to studies in other types of fibroblasts, findings in rat CF indicated that A2AR exerted 
little, if any, effect in collagen synthesis, although the selective A2AR agonist, CGS, was used in 
those studies (Dubey et al., 1998; Dubey et al., 2001; Chen et al., 2004).  The discrepancy 
between our and their studies cannot be explained by any reason other than specie difference. 
It is well recognized that A2BR and A2AR are Gs protein-coupled receptors, whose 
stimulation results in increased cAMP accumulation.  Our results support this signaling pathway 
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in mouse CF as both A2BR and A2AR stimulation increased CREB phosphorylation, and these 
effects were blunted by the PKA inhibitor H89.  These findings are consistent with the reports of 
A2BR and A2AR effects on cAMP and/or CREB in various types of fibroblasts (Liu et al., 2006; 
Liu et al., 2008; Villarreal et al., 2009; Perez-Aso et al., 2013a).  Both high concentration NECA 
and CGS increased cAMP accumulation in rat CF with A2BR being more efficacious than A2AR 
(Epperson et al., 2009). Similarly we observed that A2BR stimulation tended to increase CREB 
phosphorylation to a greater extent than did A2AR.  These effects could be due to the two-fold 
greater expression of A2BR.  Feng et al. (Feng et al., 2010)reported that NECA, at a 
concentration of 1 µM, which should have activated both A2BR and A2AR, had no effect on 
cAMP in murine CF.  
Despite our evidence supporting A2BR and A2AR coupling to Gs, stimulation of neither 
receptor decreased TGFβ-induced increases in collagen, as has been reported for β-adrenergic 
receptors in rat CF (Liu et al., 2006).  These results also conflict with previous studies in rat CF 
in which high concentrations of NECA (supportive of a role for A2BR) decreased collagen 
synthesis induced by fetal calf serum (Dubey et al., 1998; Dubey et al., 2001; Chen et al., 2004) 
and angiotensin (Villarreal et al., 2009).  Our study appears to be the first to examine the effects 
of selective A2BR stimulation on CF collagen production, and it is possible that these differences 
could be due to the use of selective vs. non-selective agonists, species differences, and or 
collagen-inducing stimuli.  The lack of effect of CGS on TGFβ-induced increases in collagen is 
consistent with reports that A2AR exerts little, if any, effect on CF collagen (Dubey et al., 1998; 
Dubey et al., 2001; Chen et al., 2004). In fact Chen et al. (Chen et al., 2004), using NECA and 
CGS, could not differentiate between the roles of A2BR and A2AR on collagen synthesis in rat 
CF.  The effects of BAY on ERK phosphorylation are consistent with previous findings in rat CF 
based on results obtained with a high concentration of the non-selective agonist NECA 
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(Epperson et al., 2009), however the effects of selective A2AR activation on ERK activation in 
CF have not been previously reported.  Our results indicate that selective A2AR and A2BR 
stimulations both increased ERK phosphorylation, and the effects of NECA on ERK 
phosphorylation were only partially blunted with MRS1754, consistent with a role for A2AR.  
Selective A2AR stimulation has been reported to increase ERK activation in human hepatic 
stellate cells (Che et al., 2007) and human dermal fibroblasts (Chan et al., 2006a).  In contrast to 
our observations, Feng et al. (Feng et al., 2010)  reported that NECA (1 µM) did not alter ERK 
phosphorylation in mouse CF.  We cannot explain the differences between our findings and 
those of Feng et al. (Feng et al., 2010), since 1 µM NECA should have stimulated both A2AR and 
A2BR, and we observed that activation of both receptors increased ERK phosphorylation. 
Our observations also indicate that A2BR and A2AR-induced increases in collagen are 
mediated via ERK- and PKA-dependent pathways.  The inhibition of adenosine receptor-induced 
collagen expression with the MEK inhibitor, U0126, is consistent with several reports that CF 
collagen synthesis is ERK-dependent (Chintalgattu and Katwa, 2004; Liu et al., 2006; Gao et al., 
2009).  Epperson et al. (Epperson et al., 2009) reported that adenosine receptor stimulation with 
NECA increased ERK phosphorylation in rat CF, but the effects of selective A2BR and A2AR 
agonists were not determined.  The same group also reported that NECA decreased angiotensin-
induced collagen production via an ERK-independent pathway (Villarreal et al., 2009).  Our 
findings that A2AR-induced increases in collagen appeared to be ERK-dependent are consistent 
with reports that U0126 inhibited CGS-induced collagen production in human dermal fibroblasts 
and human hepatic stellate cells (Chan et al., 2006a; Che et al., 2007).   
It is well known that A2BR and A2AR are coupled to Gs proteins, whose stimulation 
results in increased cAMP levels, and GPCR-induced increases in cAMP are generally 
associated with decreases in collagen synthesis (Dubey et al., 2001; Liu et al., 2006; Liu et al., 
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2008; Yokoyama et al., 2008; Villarreal et al., 2009).  In the present study neither A2BR nor 
A2AR stimulation decreased TGFβ-induced increases in collagen, and the PKA inhibitor, H89, 
blocked the collagen increases associated with both receptor agonists.  Although these findings 
appear paradoxical for Gs coupled receptors, the role of the cAMP-PKA pathway in modulating 
collagen levels is complex.  It has been reported that in human dermal fibroblasts forskolin 
decreased collagen expression, whereas A2AR stimulation increased collagen expression (Perez-
Aso et al., 2013a).  These paradoxical findings appear to be due to the 100-fold greater increase 
in cAMP induced with forskolin compare to the effect of CGS.  Likewise the β receptor agonist 
isoproterenol has been shown to produce a much greater increase in rat CF cAMP levels than 
NECA (Liu et al., 2008; Epperson et al., 2009), and isoproterenol exerts much greater decreases 
in CF collagen production than does NECA (Liu et al., 2008). 
VI. Effects of selective adenosine A2BR and A2AR activation on CF cytokine production 
Although both A2AR and A2BR have been reported to exert anti-inflammatory effects 
(Bshesh et al., 2002; Antonioli et al., 2014), A2BR activation can also induce pro-inflammatory 
cytokine production (Ryzhov et al., 2006; Wilson et al., 2011).  Our results indicate that selective 
A2BR stimulation increased pro-inflammatory IL-6, but not IL-1gene expression, whereas 
activation of A2AR exerted no effects. It is well accepted that the A2AR anti-inflammatory effect 
is mediated via Gs coupling (Bshesh et al., 2002; Antonioli et al., 2014). In contrast A2BR 
stimulation promotes IL-6 production independent of Gs coupling to cAMP (Ryzhov et al., 
2008a; Wilson et al., 2011).  Our observations are consistent with those of Feng et al. (Feng et 
al., 2010), who reported that non-selective A2BR stimulation increased IL-6 production through a 
Gq-PLC pathway in murine CF.  However these authors reported that the EC50 for NECA effects 
on IL-6 was ~ 150 nM, which is considerably lower than expected of the low affinity A2BR.  Our 
findings suggest that A2BR may exert its effects in murine CF via coupling to both Gs and Gq.  In 
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fact, Ryzhov et al. (Ryzhov et al., 2008a) concluded that A2BR exerted its effects in human mast 
cells via Gs-Gq crosstalk.  Our findings of A2BR-induced increases in collagen and IL-6 are 
consistent with reports that A2BR appear to mediate adverse remodeling and fibrosis in post-MI 
myocardium (Toldo et al., 2012; Zhang et al., 2013).   
VII. Limitations 
Although A2BR studies were conducted in both in vivo and in vitro preparations there are 
some limitations to these studies which are described below. 
1. We used semi-quantitative RT-PCR approach to evaluate the gene levels of multiple 
types of proteins in both in vivo and in vitro studies.  It would be helpful if the protein 
levels and activities (such as MMP-9 activity zymography analysis) could have been 
measured, since gene expression may not be proportional to the final protein expression.  
In fact, we tried different A2BR antibodies from various companies, but none of them 
worked. So we had to use RT-PCR to assess A2BR gene level instead of protein 
expression. 
2. Although one of the strengths of our studies is the use of whole animal adenosine A2BR 
KO mouse, this approach is also one of the limitations.  A2BR are highly expressed on 
multiple immune cells and CF, which both contribute to post-MI repair and remodeling.  
Thus we are not able to determine a cell-specific role for A2BR effects. 
3. Our data would be stronger if we had cardiac functional measurements in our post-MI 
remodeling studies. 
4. Lack of sham animals limits conclusions regarding the true effects of A2BR deletion in 
the remote zone. 
VIII. Summary and conclusions 
Our in vivo results indicated that MI induced increases in A2BR gene expression in the 
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infarct zone of WT hearts at 5-days post-MI, and A2BR KO hearts exhibited decreased TNF-α 
and MMP-9 mRNA levels at the same time point.  WT post-MI hearts also exhibited higher 
collagen-1 and -3 gene expression in the 5-day remote zone.  Morphological analysis indicated 
that A2BR deletion was associated with increased scar thickness, decreased infarct expansion, and 
less remote zone macrophage infiltration and collagen deposition at 28-days post- MI.  In vitro 
studies indicated that A2BR and A2AR are highly expressed in murine CF, and both A2 subtypes 
increased collagen-1 production via MEK and PKA pathways.  However, only A2BR activation 
increased expression of the pro-inflammatory cytokine IL-6.  These observations suggest that 
A2BR contribute to adverse remodeling and cardiac fibrosis after chronic MI, and the detrimental 
role from the receptor could be due to its pro-inflammatory and pro-fibrotic effects in CF in this 
chronic pathological process.  
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Adenosine A2B receptor (A2BR) appear to contribute to chronic inflammation.  This 
receptor is highly expressed in macrophages and cardiac fibroblasts, cells which play key roles in 
inflammation and healing following myocardial infarction (MI).  A2BR have been shown to 
induce collagen production and promote organ fibrosis, although the reports of A2BR role on MI 
are limited and conflicting.  The results of cardiac fibroblast (CF) studies however suggest that 
non-selective A2BR stimulation inhibits collagen expression.  The hypothesis of the present study 
was that deletion of A2BR reduces adverse remodeling in post-MI, and selective activation of 
A2BR increases WT murine CF collagen and pro-inflammatory cytokines production.  
In our in vivo studies, MI was induced by permanent coronary artery occlusion in male 
WT and A2BR KO mice.  Hearts were harvested at 5 or 28-day post-MI for semi quantitative RT-
PCR assay or sectioned and stained for morphological and histological studies.  In CF 
experments, effects of selective A2BR (BAY 60–6583, BAY) and A2AR (CGS-21680, CGS) 
agonists on signaling (10 min) and collagen expression (24 h) were assessed by Western blots.  
Adenosine receptor expression and agonist effects (24 h) on pro-inflammatory cytokine 
expression were analyzed with semi-quantitative real time PCR. 
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Mortality of total animals and 28-day infarct size did not differ between genotypes. A2BR 
expression was 2.7 fold greater in WT scar zone compared to remote zone.  TNF- and MMP-9 
expressions in the scar zone and collagen 1 and 3 mRNA levels in the remote zone were much 
greater in 5-day WT group without any change in macrophage infiltration.  A2BR KO hearts had 
greater scar thickness and lower infarct expansion.  Our results indicated that ablation of A2BR 
significantly decreased collagen deposition in 28-day post-MI remote zone.  We also found that 
this effect was not due to downregulation of myofibroblasts but related to decreased macrophage 
infiltration at 28-day.  Our results from CF studies indicated that A2BR gene expression was two-
fold greater than A2AR, which was comparable to angiotensin AT1R.  The A2BR agonist BAY 
and the A2AR agonist CGS both increased ERK and CREB phosphorylation.  BAY and CGS 
effects on signaling were blocked by deletion of A2BR and A2AR, respectively.  TGF-induced 
increases in collagen-1 expression were not altered by adenosine receptor agonists; in contrast, 
selective A2BR and A2AR stimulation increased collagen-1 expression, effects which were 
blunted by MEK (U0126) and PKA (H89) inhibitors.  BAY, but not CGS, increased IL-6 gene 
expression, but neither agonist showed an effect on IL-1 mRNA levels.  
Our findings that a large increase in expression of the pro-inflammatory A2BR occurs in 
the WT scar zone, and that A2BR deletion reducing adverse post-MI heart remodeling in both 
scar and remote zones, suggest a detrimental role for A2BR in this chronic pathological process, 
which could be, at least partially, through the effects on CF collagen and pro-inflammatory 
cytokine production.  
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